S. Sun

Novel Hepatitis C Virus Reporter Replicon Cell Lines Enable Efficient Antiviral Screening against Genotype 1a

Huiling Yang, W. Delaney, N. Pagratis, 2010, Antimicrobial Agents and Chemotherapy.

Susceptibility of Treatment-Naive Hepatitis C Virus (HCV) Clinical Isolates to HCV Protease Inhibitors

H. Mo, Xiaowu Chen, Karin S. Ku, 2010, Antimicrobial Agents and Chemotherapy.

Development of a replicon-based phenotypic assay for assessing the drug susceptibilities of HCV NS3 protease genes from clinical isolates.

H. Mo, Huiling Yang, W. Delaney, 2009, Antiviral research.

Mechanism of action of a pestivirus antiviral compound.

C. Rice, S. Sun, M. Collett, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Natural variation in drug susceptibility to HCV polymerase inhibitors in treatment‐naïve HCV patient isolates

H. Mo, M. D. Miller, X. Qi, 2011, Journal of viral hepatitis.

Directed evolution of gene-shuffled IFN-α molecules with activity profiles tailored for treatment of chronic viral diseases

D. Lin, S. Govindarajan, S. Bass, 2007, Proceedings of the National Academy of Sciences.